Emory University Cancer Institute, Winship Cancer Institute — Atlanta, Georgia

Emory University Cancer Institute, Winship Cancer Institute is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Emory University Cancer Institute, Winship Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma.

Sponsors: Millennium Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University Cancer Institute, Winship Cancer Institute?

Emory University Cancer Institute, Winship Cancer Institute has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University Cancer Institute, Winship Cancer Institute conducted?

Emory University Cancer Institute, Winship Cancer Institute has 1 clinical trials on record. Their work covers B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma.

Is Emory University Cancer Institute, Winship Cancer Institute accredited by Crixeo Clinical Trials?

Emory University Cancer Institute, Winship Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University Cancer Institute, Winship Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.